Key result
This review examines the safety and efficacy of antiarrhythmic drug therapy for the acute conversion and chronic management of atrial fibrillation.
Why the study?
Does antiarrhythmic therapy improve safety and efficacy in patients with atrial fibrillation?
Does antiarrhythmic therapy improve safety and efficacy in patients with atrial fibrillation?
This review discusses the safety and efficacy of antiarrhythmic therapy for the acute and chronic management of atrial fibrillation.
Offers synthesized AAD evidence for AF; leaves open optimal strategies amid evolving ablation options.
Antiarrhythmic Drugs for AF. Antiarrhythmic drugs have been used for the acute conversion of atrial fibrillation to sinus rhythm, as well as for the long‐term maintenance of sinus rhythm. In recent years, concerns regarding antiarrhythmic drug efficacy as well as safety have prompted a re‐examination of the indications for antiarrhythmic therapy in patients with atrial fibrillation. This review will focus on the safety and efficacy of antiarrhythmic therapy in the acute and chronic management of patients with atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Ganz et al. (1997) conducted a review in Atrial fibrillation. Antiarrhythmic drugs was evaluated. This review examines the safety and efficacy of antiarrhythmic drug therapy for the acute conversion and chronic management of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: